ArticleMicrobial cell factories2026
Directed screening and spatial coupling of farnesyl diphosphate synthase for enhancing menaquinone-7 production in Bacillus subtilis.
Article in Microbial cell factories, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Development of Bacillus subtilis cell factories for nutraceuticals production.World journal of microbiology & biotechnology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundMenaquinone-7 (MK-7), a highly bioactive form of vitamin K₂ with a long half-life, plays pivotal roles in preventing osteoporosis and cardiovascular diseases. A metabolically balanced MK-7-producing strain, Bacillus subtilis BS016, has been engineered. However, its biosynthetic efficiency remains hindered by bottlenecks, such as low isoprenoid side-chain elongation efficiency.
resultsTo address this limitation, a thermophilic farnesyl diphosphate (FPP) synthase from Geobacillus stearothermophilus, characterized by high activity and stability, was identified via database mining. This enzyme was modularly assembled with the endogenous hepS-menG-hepT operon in B. subtilis BS016, driven by the strong promoter Phbs. A synergistic expression cassette was constructed to achieve spatial co-localization of FPP synthesis with downstream isoprenoid side-chain elongation. The resulting engineered strain BS018 achieved a flask yield of 91.1 mg/L, representing an 11% increase, and maintained a stable titer of 87.9 mg/L in a 5-L fermenter. Further optimisation of fermentation conditions (liquid loading, 50 mL/500 mL; initial pH, 7.0; inoculum dose, 8%) ultimately elevated a flask yield to 109.6 mg/L.
conclusionThis study demonstrates that the directed screening of high activity heterologous enzymes, combined with the spatial co-assembly of endogenous pathways, can effectively reconstruct and enhance metabolic flux. This integrated strategy, combining directed enzyme screening with spatial pathway assembly, provides a generalizable framework for constructing efficient cell factories not only for vitamin K₂ but also for other high-value terpenoids.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.